These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34683930)

  • 21. Comparison of electrospun and solvent cast polylactic acid (PLA)/poly(vinyl alcohol) (PVA) inserts as potential ocular drug delivery vehicles.
    Bhattarai RS; Das A; Alzhrani RM; Kang D; Bhaduri SB; Boddu SHS
    Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():895-903. PubMed ID: 28532107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melt-Cast Noninvasive Ocular Inserts for Posterior Segment Drug Delivery.
    Balguri SP; Adelli GR; Tatke A; Janga KY; Bhagav P; Majumdar S
    J Pharm Sci; 2017 Dec; 106(12):3515-3523. PubMed ID: 28778424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable hybrid polymeric membranes for ocular drug delivery.
    Jain D; Carvalho E; Banerjee R
    Acta Biomater; 2010 Apr; 6(4):1370-9. PubMed ID: 19900594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Bioavailability and Anticancer Effect of Curcumin-Loaded Electrospun Nanofiber: In Vitro and In Vivo Study.
    Wang C; Ma C; Wu Z; Liang H; Yan P; Song J; Ma N; Zhao Q
    Nanoscale Res Lett; 2015 Dec; 10(1):439. PubMed ID: 26573930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical ocular drug delivery systems: Innovations for an unmet need.
    Yang Y; Lockwood A
    Exp Eye Res; 2022 May; 218():109006. PubMed ID: 35248559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibuprofen Loaded Electrospun Polymeric Nanofibers: A Strategy to Improve Oral Absorption.
    Panda DS; Alruwaili NK; Pattnaik S; Swain K
    Acta Chim Slov; 2022 Jun; 69(2):483-488. PubMed ID: 35861064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Patents on Polymeric Electrospun Nanofibers and Their Applications in Drug Delivery.
    Patel G; Yadav BKN
    Recent Pat Nanotechnol; 2018; 12(3):174-179. PubMed ID: 30332979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ophthalmic adverse drug reactions to systemic drugs: a systematic review.
    Miguel A; Henriques F; Azevedo LF; Pereira AC
    Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):221-33. PubMed ID: 24464938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics.
    Cong YY; Fan B; Zhang ZY; Li GY
    Int Ophthalmol; 2023 Jul; 43(7):2575-2588. PubMed ID: 36715956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic applications of electrospun nanofibers for drug delivery systems.
    Son YJ; Kim WJ; Yoo HS
    Arch Pharm Res; 2014 Jan; 37(1):69-78. PubMed ID: 24234913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the Application of Electrospun Drug-Loaded Nanofibers in the Treatment of Oral Ulcers.
    Zhou Y; Wang M; Yan C; Liu H; Yu DG
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled dual delivery of BMP-2 and dexamethasone by nanoparticle-embedded electrospun nanofibers for the efficient repair of critical-sized rat calvarial defect.
    Li L; Zhou G; Wang Y; Yang G; Ding S; Zhou S
    Biomaterials; 2015 Jan; 37():218-29. PubMed ID: 25453952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrospun fibers: an innovative delivery method for the treatment of bone diseases.
    Mao Y; Zhao Y; Guan J; Guan J; Ye T; Chen Y; Zhu Y; Zhou P; Cui W
    Expert Opin Drug Deliv; 2020 Jul; 17(7):993-1005. PubMed ID: 32394737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrospun nanofibers - A promising solid in-situ gelling alternative for ocular drug delivery.
    Göttel B; de Souza E Silva JM; Santos de Oliveira C; Syrowatka F; Fiorentzis M; Viestenz A; Viestenz A; Mäder K
    Eur J Pharm Biopharm; 2020 Jan; 146():125-132. PubMed ID: 31816391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies.
    Rathod LV; Kapadia R; Sawant KK
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():529-540. PubMed ID: 27987741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and development of dual drug-loaded nanofibrous inserts for ophthalmic sustained delivery of AMK and VAN: Pharmacokinetic study in rabbit's eye.
    Taghe S; Mirzaeei S; Hosseinkhani T
    Int J Pharm; 2024 May; 656():124056. PubMed ID: 38548072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmic nano-bioconjugates: critical challenges and technological advances.
    Sanap SN; Bisen AC; Agrawal S; Kedar A; Bhatta RS
    Ther Deliv; 2023 Jul; 14(7):419-441. PubMed ID: 37535389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microstructure and Biological Properties of Electrospun In Situ Polymerization of Polycaprolactone-Graft-Polyacrylic Acid Nanofibers and Its Composite Nanofiber Dressings.
    Huang YJ; Huang CL; Lai RY; Zhuang CH; Chiu WH; Lee KM
    Polymers (Basel); 2021 Dec; 13(23):. PubMed ID: 34883754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of polycaprolactone-based electrospun nanofibers containing timolol maleate as a sustained-release device for treatment of glaucoma:
    Mirzaeei S; Faryadras FB; Mehrandish S; Rezaei L; Daneshgar F; Karami A
    Res Pharm Sci; 2022 Oct; 17(5):468-481. PubMed ID: 36386485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functionalized silk fibroin nanofibers as drug carriers: Advantages and challenges.
    Farokhi M; Mottaghitalab F; Reis RL; Ramakrishna S; Kundu SC
    J Control Release; 2020 May; 321():324-347. PubMed ID: 32061791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.